Clinical Trials Browser

Phase 1/2 × Lymphoma, Non-Hodgkin × Thiotepa × Clear all

Hodgkin Disease, Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Hematologic Neoplasms, Neoplasms, Plasma Cell

NCT05021770 2021-08-26

Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

Phase 1/2 Unknown

29 enrolled

Lymphoid

Lymphoma, Non-Hodgkin

NCT01050764 2018-06-27

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells

Phase 1/2 Terminated

10 enrolled 13 charts

LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Clinical Trials

Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps

Orelabrutinib in Combination With Thiotepa in Refractory and Relapsed Primary CNS Lymphoma

Haploidentical Allogeneic Transplant With Post-transplant Infusion of Regulatory T-cells